Breadcrumb

What's New at the RI-MUHC ?

Major scientific achievement gives hope to families affected by 4H leukodystrophy

RI-MUHC team creates first representative model of this rare disease

Severe maternal complications at childbirth: a recurring hazard?

New study paints clear picture of maternal health within the population of Quebec

More than 75% of Canadians had immunity to SARS-CoV-2 due to infection by March 2023

Scientists used aggregate data to estimate trends in both infection-acquired and vaccine-induced...

Medical writing: caution warranted if using ChatGPT

Researchers from CHU Sainte-Justine and the Montreal Children's Hospital recently asked ChatGPT 20 medical questions...

New understanding of processes involved in breast cancer metastasis

A study led by RI-MUHC researcher Nathalie Lamarche-Vane reveals the mechanisms underlying regulation...

Unravelling mechanisms for cardiovascular therapeutics

RI-MUHC researchers co-lead a team that combines novel pharmacology with structural biology and computational modelling to discover new domains...

All airway trees are not created equal

An RI-MUHC study suggests that lung development in early life has an impact on the risk of premature death

World-first clinical trial to help millions of people with penicillin allergies

The PALACE study, an international research endeavour, has evaluated a safer and simpler approach to penicillin allergy testing

New research aims to make prostate cancer prognostics more precise

A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer

Leading the way towards improved treatment for atrial fibrillation

Always on the lookout for major developments in electrophysiology, MUHC clinical teams work closely with research teams at the RI-MUHC to offer the most innovative treatments to patients

Learn more about the RI-MUHC